Effects of chemokine (C-C motif) ligand 1 on microglial function

Biochemical and Biophysical Research Communications

Volumn 436, Issue 3, 2013, Pages 455-461

  Akimoto, Nozomi ^a   Ifuku, Masataka ^a   Mori, Yuki ^a   Noda, Mami ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

CCL 1; Chemotaxis; Cytokines; Microglia; Phagocytosis; Proliferation

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CCL1 CHEMOKINE; CHEMOKINE RECEPTOR CCR8; INTERLEUKIN 6; MESSENGER RNA; NITRITE;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL FUNCTION; CELL MIGRATION; CELL MOTILITY; CELL PHAGOCYTOSIS; CELL PROLIFERATION; CHEMOTAXIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; MICROGLIA; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

Γ-AMINO BUTYRIC ACID; 4′,6′-DIAMIDINO-2-PHENYLINDOLE DIHYDROCHLORIDE; BASE PAIR; BDNF; BP; BRAIN-DERIVED NEUROTROPHIC FACTOR; CCL-1; CCL-2; CCL-21; CCR-8; CDNA; CENTRAL NERVOUS SYSTEM; CHEMOKINE (C-C MOTIF) LIGAND 1; CHEMOKINE (C-C MOTIF) LIGAND 2; CHEMOKINE (C-C MOTIF) LIGAND 21; CHEMOKINE (C-C MOTIF) RECEPTOR 8; CHEMOKINE (CX3C MOTIF) LIGAND 1; CHEMOTAXIS; CNS; COMPLEMENTARY DNA; CX3CL-1; CYTOKINES; DAPI; DMEM; DORSAL ROOT GANGLIA; DRG; DULBECCO'S MODIFIED EAGLE MEDIUM; FBS; FETAL BOVINE SERUM; GABA; GFAP; GLIAL FIBRILLARY ACID PROTEIN; IBA1; IL-1Β; IL-6; INTERLEUKIN 1Β; INTERLEUKIN 6; IONIZED CALCIUM-BINDING ADAPTER MOLECULE 1; MAP2; MESSENGER RNA; MICROGLIA; MICROTUBULE-ASSOCIATED PROTEIN 2; MRNA; NITRIC OXIDE; NMDA RECEPTOR 2B; NO; NR2B; PBS; PHAGOCYTOSIS; PHOSPHATE BUFFERED SALINE; PROLIFERATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RT-PCR; TCA-3; THYMUS-DERIVED CHEMOTACTIC AGENT 3; TNF-Α; TUMOUR NECROSIS FACTOR-Α;

ANIMALS; ASTROCYTES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL COUNT; CELL PROLIFERATION; CELL SHAPE; CELLS, CULTURED; CHEMOKINE CCL1; CHEMOTAXIS; GENE EXPRESSION REGULATION; INTERLEUKIN-6; KI-67 ANTIGEN; MICE; MICROGLIA; NEURONS; NITRITES; PHAGOCYTOSIS; PRIMARY CELL CULTURE; RNA, MESSENGER;

EID: 84879882886     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.126     Document Type: Article

References (27)

1. Luo Y., Laning J., Devi S., Mak J., Schall T.J., Dorf M.E. Biologic activities of the murine beta-chemokine TCA3. J. Immunol. 1994, 153:4616-4624.
2. Akimoto N., Honda K., Uta D., Beppu K., Ushijima Y., Matsuzaki Y., Nakashima S., Kido M.A., Imoto K., Takano Y., Noda M. CCL-1 in the spinal cord contributes to neuropathic pain induced by nerve injury. Cell Death Dis. 2013, http://dx.doi.org/10.1038/cddis.2013.198 (in press).
3. Kim S.U., de Vellis J. Microglia in health and disease. J. Neurosci. Res. 2005, 81:302-313.
4. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996, 19:312-318.
5. Inoue K., Tsuda M. Microglia and neuropathic pain. Glia 2009, 57:1469-1479.
6. Biber K., Vinet J., Boddeke H.W. Neuron-microglia signaling: chemokines as versatile messengers. J. Neuroimmunol. 2008, 198:69-74.
7. Kettenmann H., Hanisch U.K., Noda M., Verkhratsky A. Physiology of microglia. Physiol. Rev. 2011, 91:461-553.
8. Draheim H.J., Prinz M., Weber J.R., Weiser T., Kettenmann H., Hanisch U.K. Induction of potassium channels in mouse brain microglia: cells acquire responsiveness to pneumococcal cell wall components during late development. Neuroscience 1999, 89:1379-1390.
9. 2+ exchanger. J. Neurosci. 2007, 27:13065-13073.
10. Noda M., Kariura Y., Pannasch U., Nishikawa K., Wang L., Seike T., Ifuku M., Kosai Y., Wang B., Nolte C., Aoki S., Kettenmann H., Wada K. Neuroprotective role of bradykinin because of the attenuation of pro-inflammatory cytokine release from activated microglia. J. Neurochem. 2007, 101:397-410.
11. Nolte C., Kirchhoff F., Kettenmann H. Epidermal growth factor is a motility factor for microglial cells in vitro: evidence for EGF receptor expression. Eur. J. Neurosci. 1997, 9:1690-1698.
12. Mika J., Osikowicz M., Rojewska E., Korostynski M., Wawrzczak-Bargiela A., Przewlocki R., Przewlocka B. Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain. Eur. J. Pharmacol. 2009, 623:65-72.
13. Tsuda M., Shigemoto-Mogami Y., Koizumi S., Mizokoshi A., Kohsaka S., Salter M.W., Inoue K. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 2003, 424:778-783.
14. Cross A.K., Woodroofe M.N. Chemokines induce migration and changes in actin polymerization in adult rat brain microglia and a human fetal microglial cell line in vitro. J. Neurosci. Res. 1999, 55:17-23.
15. Zhang M., Xu G., Liu W., Ni Y., Zhou W. Role of fractalkine/CX3CR1 interaction in light-induced photoreceptor degeneration through regulating retinal microglial activation and migration. PLoS One 2012, 7:e35446.
16. Maciejewski-Lenoir D., Chen S., Feng L., Maki R., Bacon K.B. Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. J. Immunol. 1999, 163:1628-1635.
17. Napoli I., Neumann H. Microglial clearance function in health and disease. Neuroscience 2009, 158:1030-1038.
18. Blinzinger K., Kreutzberg G. Displacement of synaptic terminals from regenerating motoneurons by microglial cells. Z. Zellforsch. Mikrosk. Anat. 1968, 85:145-157.
19. Trapp B.D., Wujek J.R., Criste G.A., Jalabi W., Yin X., Kidd G.J., Stohlman S., Ransohoff R. Evidence for synaptic stripping by cortical microglia. Glia 2007, 55:360-368.
20. Mitchison T.J., Cramer L.P. Actin-based cell motility and cell locomotion. Cell 1996, 84:371-379.
21. Downey G.P. Mechanisms of leukocyte motility and chemotaxis. Curr. Opin. Immunol. 1994, 6:113-124.
22. Rabinovitch M. Professional and non-professional phagocytes: an introduction. Trends Cell Biol. 1995, 5:85-87.
23. Coull J.A., Beggs S., Boudreau D., Boivin D., Tsuda M., Inoue K., Gravel C., Salter M.W., De Koninck Y. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005, 438:1017-1021.
24. Kawasaki Y., Zhang L., Cheng J.K., Ji R.R. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J. Neurosci. 2008, 28:5189-5194.
25. Ji R.R., Suter M.R. P38 MAPK, microglial signaling, and neuropathic pain. Mol. Pain 2007, 3:33.
26. Geng S.J., Liao F.F., Dang W.H., Ding X., Liu X.D., Cai J., Han J.S., Wan Y., Xing G.G. Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation. Exp. Neurol. 2010, 222:256-266.
27. Martucci C., Trovato A.E., Costa B., Borsani E., Franchi S., Magnaghi V., Panerai A.E., Rodella L.F., Valsecchi A.E., Sacerdote P., Colleoni M. The purinergic antagonist PPADS reduces pain related behaviours and interleukin-1 beta, interleukin-6, iNOS and nNOS overproduction in central and peripheral nervous system after peripheral neuropathy in mice. Pain 2008, 137:81-95.